Oral products

Skyepharma applies its proprietary oral drug delivery technologies and capabilities to the development of both new chemical entities and differentiated formulations of existing products, in order to provide clinical benefits for patients, to offer additional proprietary protection to innovators, and to support Life Cycle Management.

Skyepharma’s oral drug delivery technologies are used in 10 approved products that are currently sold in more than 80 different countries by many of the world’s leading pharmaceutical companies.

We also have a number of oral products in various stages of development, some of which are available for licensing.

Range of oral modified release pharmaceutical products, developed by Skyepharma

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.